HRP20051019A2 - A method for the preparation of enantiomerically pure mirtazapine - Google Patents

A method for the preparation of enantiomerically pure mirtazapine

Info

Publication number
HRP20051019A2
HRP20051019A2 HR20051019A HRP20051019A HRP20051019A2 HR P20051019 A2 HRP20051019 A2 HR P20051019A2 HR 20051019 A HR20051019 A HR 20051019A HR P20051019 A HRP20051019 A HR P20051019A HR P20051019 A2 HRP20051019 A2 HR P20051019A2
Authority
HR
Croatia
Prior art keywords
preparation
enantiomerically pure
mirtazapine
acid
pure mirtazapine
Prior art date
Application number
HR20051019A
Other languages
English (en)
Croatian (hr)
Inventor
Hubertus Wieringa Johannes
Antonius Martinus Van De Ven Adrianus
Johannes Kemperman Gerardus
Original Assignee
Akzo Nobel N.V.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Akzo Nobel N.V. filed Critical Akzo Nobel N.V.
Publication of HRP20051019A2 publication Critical patent/HRP20051019A2/xx

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D401/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/04Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/24Antidepressants
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D471/00Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/12Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains three hetero rings
    • C07D471/14Ortho-condensed systems

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Neurosurgery (AREA)
  • Biomedical Technology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Neurology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pain & Pain Management (AREA)
  • Psychiatry (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
HR20051019A 2003-07-10 2005-12-22 A method for the preparation of enantiomerically pure mirtazapine HRP20051019A2 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP03102095 2003-07-10
PCT/EP2004/051357 WO2005005410A1 (en) 2003-07-10 2004-07-05 A method for the preparation of enantiomerically pure mirtazapine

Publications (1)

Publication Number Publication Date
HRP20051019A2 true HRP20051019A2 (en) 2006-02-28

Family

ID=34042934

Family Applications (1)

Application Number Title Priority Date Filing Date
HR20051019A HRP20051019A2 (en) 2003-07-10 2005-12-22 A method for the preparation of enantiomerically pure mirtazapine

Country Status (36)

Country Link
US (2) US8058436B2 (es)
EP (1) EP1656365B1 (es)
JP (1) JP4668184B2 (es)
KR (1) KR20060056315A (es)
CN (1) CN100558722C (es)
AR (1) AR046494A1 (es)
AT (1) ATE433965T1 (es)
AU (1) AU2004255874B2 (es)
BR (1) BRPI0412447A (es)
CA (1) CA2531165C (es)
CO (1) CO5640123A2 (es)
CY (1) CY1109327T1 (es)
DE (1) DE602004021605D1 (es)
DK (1) DK1656365T3 (es)
EC (1) ECSP066271A (es)
ES (1) ES2327123T3 (es)
HK (1) HK1086841A1 (es)
HR (1) HRP20051019A2 (es)
IL (1) IL172549A0 (es)
IS (1) IS2674B (es)
LT (1) LT5382B (es)
LV (1) LV13441B (es)
MX (1) MXPA06000325A (es)
NO (1) NO20056175L (es)
NZ (1) NZ544360A (es)
PE (1) PE20050323A1 (es)
PL (1) PL1656365T3 (es)
PT (1) PT1656365E (es)
RS (1) RS20050972A (es)
RU (1) RU2352566C2 (es)
SG (1) SG144914A1 (es)
SI (1) SI1656365T1 (es)
TW (1) TWI335915B (es)
UA (1) UA83666C2 (es)
WO (1) WO2005005410A1 (es)
ZA (1) ZA200600019B (es)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1930325A4 (en) * 2005-09-26 2010-02-24 Sumitomo Chemical Co METHOD FOR PRODUCING AN OPTICALLY ACTIVE PIPERAZINE COMPOUND
JP5080050B2 (ja) * 2005-09-26 2012-11-21 住友化学株式会社 光学活性なピペラジン化合物の製造方法
TW200808804A (en) * 2006-05-22 2008-02-16 Organon Nv Mirtazapine for the treatment of neuropathic pain
TW200815370A (en) * 2006-06-16 2008-04-01 Organon Nv Stereoselective synthesis of (S)-1-methyl-3-phenylpiperazine
EP2119709A4 (en) * 2007-02-09 2011-08-17 Kaneka Corp PROCESS FOR PREPARING OPTICALLY ACTIVE 2-ARYLPIPERAZINE DERIVATIVE
JP5192707B2 (ja) * 2007-03-22 2013-05-08 住友化学株式会社 ミルタザピンの製造方法
US7994314B2 (en) 2007-04-11 2011-08-09 N.V. Organon Method for the preparation of an enantiomerically pure benzazepine
MX2009010967A (es) 2007-04-11 2009-12-15 Organon Nv Un metodo para la preparacion de mirtazapina.
KR101485418B1 (ko) * 2013-05-29 2015-01-26 주식회사 메디켐코리아 고순도 미르타자핀의 제조방법
DK3261645T3 (da) 2015-02-27 2021-06-07 Dechra Ltd Stimulering af appetit, håndtering af vægttab og behandling af anoreksi hos hunde og katte
KR102540021B1 (ko) * 2020-12-02 2023-06-07 (주)유케이케미팜 대량 생산에 적합한 미르타자핀의 제조방법

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3959470A (en) * 1972-11-28 1976-05-25 Mikhail Davidovich Mashkovsky Psychotropic medicinal preparation
NL189199C (nl) * 1975-04-05 1993-02-01 Akzo Nv Werkwijze ter bereiding van farmaceutische preparaten met werking op het centraal zenuwstelsel op basis van benz(aryl)azepinederivaten, de verkregen gevormde farmaceutische preparaten, alsmede werkwijze ter bereiding van de toe te passen benz(aryl)azepinederivaten.
PT95522B (pt) * 1989-10-05 1997-08-29 Sankyo Co Processo para a preparacao de novos compostos tetraciclicos com accao anti-alergica e anti-asmatica e de composicoes farmaceuticas que os contem
PT1030667E (pt) 1997-11-14 2005-06-30 Akzo Nobel Nv Utilizacao de mirtazapina para o fabrico de um medicamento para o tratamento de apenas do sono
JPH11222407A (ja) * 1997-11-14 1999-08-17 Sankyo Co Ltd 新規殺菌剤
PL366289A1 (en) * 1999-04-19 2005-01-24 Teva Pharmaceutical Industries Ltd. Novel synthesis and crystallization of piperazine ring-containing compounds
US20030069417A1 (en) * 1999-04-19 2003-04-10 Claude Singer Novel synthesis and crystallization of piperazine ring-containing compounds
US6068695A (en) * 1999-07-13 2000-05-30 Bayer Corporation Process for the continuous preparation of quinacridones
AU6476300A (en) 1999-09-30 2001-05-10 Sumika Fine Chemicals Co., Ltd. Process for the preparation of a piperazine derivative
WO2001042239A1 (fr) * 1999-12-13 2001-06-14 Sumika Fine Chemicals Co., Ltd. Procede de preparation d'un compose pyridinemethanol
PL206073B1 (pl) 2000-02-11 2010-06-30 Organon Nv Zastosowanie mirtazapiny do wytwarzania leku
JP2001342188A (ja) * 2000-03-27 2001-12-11 Takeda Chem Ind Ltd 縮合ピラゾール誘導体、その製造法および用途
TW200538100A (en) * 2004-04-21 2005-12-01 Akzo Nobel Nv Mirtazapine salts

Also Published As

Publication number Publication date
WO2005005410A1 (en) 2005-01-20
SG144914A1 (en) 2008-08-28
CO5640123A2 (es) 2006-05-31
JP2009513537A (ja) 2009-04-02
UA83666C2 (ru) 2008-08-11
DK1656365T3 (da) 2009-09-14
IS8184A (is) 2005-12-15
RU2006103992A (ru) 2006-06-27
HK1086841A1 (en) 2006-09-29
IS2674B (is) 2010-09-15
ZA200600019B (en) 2007-01-31
TWI335915B (en) 2011-01-11
US20060229300A1 (en) 2006-10-12
PT1656365E (pt) 2009-09-01
NO20056175L (no) 2006-01-23
ATE433965T1 (de) 2009-07-15
BRPI0412447A (pt) 2006-09-19
PE20050323A1 (es) 2005-05-16
CN1820000A (zh) 2006-08-16
EP1656365B1 (en) 2009-06-17
SI1656365T1 (sl) 2009-10-31
CA2531165C (en) 2011-08-30
LT5382B (lt) 2006-11-27
AR046494A1 (es) 2005-12-14
IL172549A0 (en) 2006-04-10
ES2327123T3 (es) 2009-10-26
US8058436B2 (en) 2011-11-15
AU2004255874A1 (en) 2005-01-20
CN100558722C (zh) 2009-11-11
CA2531165A1 (en) 2005-01-20
RU2352566C2 (ru) 2009-04-20
ECSP066271A (es) 2006-07-28
JP4668184B2 (ja) 2011-04-13
MXPA06000325A (es) 2006-03-30
TW200510426A (en) 2005-03-16
NZ544360A (en) 2008-05-30
CY1109327T1 (el) 2014-07-02
PL1656365T3 (pl) 2009-10-30
RS20050972A (en) 2008-06-05
EP1656365A1 (en) 2006-05-17
LV13441B (en) 2006-08-20
DE602004021605D1 (de) 2009-07-30
US20100179319A1 (en) 2010-07-15
LT2005107A (en) 2006-06-27
AU2004255874B2 (en) 2010-10-28
KR20060056315A (ko) 2006-05-24

Similar Documents

Publication Publication Date Title
HRP20051019A2 (en) A method for the preparation of enantiomerically pure mirtazapine
ECSP055883A (es) Nuevos derivados de piridazin-3(2h)-ona
ATE417051T1 (de) Polymorphe von clopidogrel-hydrogensulfat
RS51341B (en) INTERMEDIATE COMPOUNDS FOR THE TRANS-5-CHLOR-2-METHYL-2,3A, 12B-TETRAHYDRO-1H-DIBENZE [2,3; 6,7] OXEPINO [4,5-C] Pyrrole
DE60313625D1 (de) Metalloxyphthalocyaninverbindungen
ATE338461T1 (de) Pyrazolpyrimidinfungizide
EA200600621A1 (ru) Производные тетрагидронафталина, способ их получения и их применение в качестве противовоспалительных средств
DE602004005888D1 (de) Herstellung von selbstorganisierten monoschichten
MY144633A (en) New tricyclic derivatives, method of preparing same and pharmaceutical compositions containing them
ATE527258T1 (de) Pyrroloä2,3-cüpyridinverbindung, verfahren zu deren herstellung und anwendung
HRP20051005A2 (en) Process for the preparation of nonpeptide substituted spirobenzoazepine derivatives
EA200700550A1 (ru) Производные алкилидентетрагидронафталина, способ их получения и их применение в качестве противовоспалительных средств
GB0411929D0 (en) Organic compounds
ATE526312T1 (de) Verfahren zur herstellung von reinen 4- pyrrolidinophenylbenzyletherderivaten als maob- inhibitoren
NO20061344L (no) Imidazopyridinderivater som induserbare NO-syntaseoinhibitorer
UY29498A1 (es) Derivados de aminoácidos
ATE514702T1 (de) Verfahren zur herstellung von clopidogrel und dabei verwendete zwischenprodukte
ATE410485T1 (de) Härtbare farbige zusammensetzung, farbfilter und verfahren zu deren herstellung
ATE423096T1 (de) Verfahren zur herstellung von 2- azabicycloä3.3.0üoctan-3-carbonsäurederivaten
ATE466003T1 (de) Herstellung von 2-aminothiazol-5- carbonsäurederivaten
ECSP056103A (es) Tratamiento de pigmentos de alto rendimiento
ATE415404T1 (de) Lösungsmittelfreies verfahren zur herstellung von diketopyrrolopyrrol-derivaten
DE502007006121D1 (de) Elektrochemische herstellung sterisch gehinderter amine
ATE279191T1 (de) Trizyklische dihydrobenzofurane, verfahren zu deren herstellung und mittel
BRPI0414873A (pt) derivados de imidazopiridina como inibidores de no-sintase induzìveis

Legal Events

Date Code Title Description
A1OB Publication of a patent application
ARAI Request for the grant of a patent on the basis of the submitted results of a substantive examination of a patent application
PPPP Transfer of rights

Owner name: N.V. ORGANON, NL

ODRP Renewal fee for the maintenance of a patent

Payment date: 20110629

Year of fee payment: 8

OBST Application withdrawn